Atlas Capital Advisors LLC Adverum Biotechnologies, Inc. Transaction History

Atlas Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$0.96 - $9.68 $4,080 - $41,140	4,250 New	4,250 $4.04 Million
Q2 2022 Aug 16, 2022	SELL	$0.81 - $1.34 $3,442 - $5,695	-4,250 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$9.26 - $14.36 $20,372 - $31,592	-2,200 Reduced 34.11%	4,250 $41,000
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $63,468 - $91,977	6,450 New	6,450 $69,000
Q3 2020 Oct 23, 2020	SELL	$10.3 - $21.64 $2,060 - $4,328	-200 Closed	0 $0
Q2 2020 Jul 28, 2020	SELL	$8.53 - $25.64 $23,210 - $69,766	-2,721 Reduced 93.15%	200 $4,000
Q1 2020 May 04, 2020	BUY	$7.98 - $16.32 $23,309 - $47,670	2,921 New	2,921 $28,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $391M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.